www.fdanews.com/articles/101827-innovex-to-promote-pharmamar-s-yondelis-cancer-treatment
Innovex to Promote PharmaMar's Yondelis Cancer Treatment
December 5, 2007
Innovex announced a services agreement with PharmaMar, a subsidiary of Zeltia SA, to recruit, train and deploy a specialized oncology sales team in Western Europe to promote Yondelis, PharmaMar’s treatment for soft tissue sarcoma. PharmaMar, which holds the marketing authorization, will be responsible for marketing the drug.
Earthtimes.org
Earthtimes.org